OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progestin-associated shift of meningioma mutational landscape
Matthieu Peyre, S. Gaillard, C. De Marcellus, et al.
Annals of Oncology (2017) Vol. 29, Iss. 3, pp. 681-686
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
Alain Weill, Pierre Nguyen, Moujahed Labidi, et al.
BMJ (2021), pp. n37-n37
Open Access | Times Cited: 107

Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A. Williams, Sandro Santagata, Hiroaki Wakimoto, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 80

Molecular alterations in meningioma: prognostic and therapeutic perspectives
Cristina Birzu, Matthieu Peyre, Felix Sahm
Current Opinion in Oncology (2020) Vol. 32, Iss. 6, pp. 613-622
Closed Access | Times Cited: 72

High‐Dose Cyproterone Acetate and Intracranial Meningioma: Impact of the Risk Minimisation Measures Implemented in France in 2018–2019
Noémie Roland, Anke Neumann, Bérangère Baricault, et al.
Pharmacoepidemiology and Drug Safety (2025) Vol. 34, Iss. 1
Open Access | Times Cited: 1

Genetic Alterations of TRAF Proteins in Human Cancers
Sining Zhu, Juan Jin, Samantha Gokhale, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 80

Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study
Léa Hoisnard, Moussa Laanani, Thibault Passeri, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 9, pp. 2801-2809
Open Access | Times Cited: 35

EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6

A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas
Keng Siang Lee, John J.Y. Zhang, Ramez Kirollos, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27

Management of meningioma
Philipp Euskirchen, Matthieu Peyre
La Presse Médicale (2018) Vol. 47, Iss. 11-12, pp. e245-e252
Closed Access | Times Cited: 43

New Insights into Expression of Hormonal Receptors by Meningiomas
Sylvain Portet, Tania Banor, J Bousquet, et al.
World Neurosurgery (2020) Vol. 140, pp. e87-e96
Open Access | Times Cited: 35

Meningioma: Molecular Updates from the 2021 World Health Organization Classification of CNS Tumors and Imaging Correlates
Neetu Soni, Manish Ora, Girish Bathla, et al.
American Journal of Neuroradiology (2024) Vol. 46, Iss. 2, pp. 240-250
Closed Access | Times Cited: 4

The Association between Medroxyprogesterone Acetate Exposure and Meningioma
Russell Griffin
Cancers (2024) Vol. 16, Iss. 19, pp. 3362-3362
Open Access | Times Cited: 4

Advancements in the research of the structure, function, and disease-related roles of ARMC5
Yang Qu, Fan Yang, Yafang Deng, et al.
Frontiers of Medicine (2025)
Closed Access

Medroxyprogesterone acetate and meningioma: a global issue
Noémie Roland, Sébastien Froelich, Alain Weill
Frontiers in Global Women s Health (2025) Vol. 6
Open Access

Parasellar Meningiomas
Thomas Graillon, Jean Régis, Anne Barlier, et al.
Neuroendocrinology (2020) Vol. 110, Iss. 9-10, pp. 780-796
Open Access | Times Cited: 28

Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma
Edouard Samarut, Alexandre Lugat, Aymeric Amelot, et al.
Journal of Neuro-Oncology (2021) Vol. 152, Iss. 1, pp. 115-123
Open Access | Times Cited: 25

Female gender and exogenous progesterone exposition as risk factors for spheno-orbital meningiomas
Caroline Apra, Paul Roblot, Abdu Alkhayri, et al.
Journal of Neuro-Oncology (2020) Vol. 149, Iss. 1, pp. 95-101
Open Access | Times Cited: 26

Meningiomas in Premenopausal Women: Role of the Hormone Related Conditions
Francesco Maiuri, Giuseppe Mariniello, Teresa Somma, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 26

Hormone therapies in meningioma-where are we?
Danielle Miyagishima, Jennifer Moliterno, Elizabeth B. Claus, et al.
Journal of Neuro-Oncology (2022) Vol. 161, Iss. 2, pp. 297-308
Open Access | Times Cited: 14

Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment
Sylvain Portet, Rania Naoufal, Gaëlle Tachon, et al.
Neuro-Oncology Advances (2019) Vol. 1, Iss. 1
Open Access | Times Cited: 23

The risk of developing a meningioma during and after pregnancy
Jenny Pettersson-Segerlind, Tiit Mathiesen, Adrian Elmi‐Terander, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20

Intracranial Meningiomas Decrease in Volume on Magnetic Resonance Imaging After Discontinuing Progestin
Eduard Voormolen, Pierre Olivier Champagne, Elena Roca, et al.
Neurosurgery (2021) Vol. 89, Iss. 2, pp. 308-314
Closed Access | Times Cited: 18

Page 1 - Next Page

Scroll to top